Actinium Pharmaceuticals Inc
ATNM1.650USD
+0.040+2.48%
交易中 （美东）报价延迟15分钟
51.47M总市值
亏损市盈率 TTM
关于 Actinium Pharmaceuticals Inc 公司
Actinium Pharmaceuticals, Inc. 是一家后期生物制药公司。该公司致力于开发靶向放射疗法，以提高现有肿瘤疗法失败患者的生存率。该公司的先进候选药物包括 Iomab-B（pre-BLA 和 MAA (EU)）和 Actimab-A。Iomab-B 是骨髓移植前的诱导和调理剂。Actimab-A 是一种治疗剂，已证明有潜力延长复发和难治性急性髓性白血病患者的生存期。该公司专注于用于其他血癌的先进 Iomab-B 和下一代调理候选药物 Iomab-ACT，以改善细胞和基因治疗结果。该公司拥有专利申请，包括与在回旋加速器中制造同位素 Ac-225 相关的多项专利。Actinium-225 是一种强效的阿尔法粒子发射体，具有高线性能量转移能力，能够通过 DNA 双链断裂杀死目标癌细胞。
公司简介
公司代码ATNM
公司名称Actinium Pharmaceuticals Inc
上市日期Mar 26, 2014
CEOMr. Sandesh (Andes) Seth
员工数量37
证券类型Ordinary Share
年结日Mar 26
公司地址100 Park Ave., 23Rd Floor
城市NEW YORK
上市交易所NYSE American Consolidated
国家United States of America
邮编10017
电话16466773870
网址https://www.actiniumpharma.com/
公司代码ATNM
上市日期Mar 26, 2014
CEOMr. Sandesh (Andes) Seth
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Sandesh (Andes) Seth
Mr. Sandesh (Andes) Seth
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
5.38K
--
Dr. Ajit S. Shetty, Ph.D.
Dr. Ajit S. Shetty, Ph.D.
Independent Director
Independent Director
757.00
--
Mr. Richard I. Steinhart
Mr. Richard I. Steinhart
Independent Director
Independent Director
316.00
--
Mr. Steve O'Loughlin
Mr. Steve O'Loughlin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. June S. Almenoff, M.D., Ph.D.
Dr. June S. Almenoff, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Jeffrey W. Chell, M.D.
Dr. Jeffrey W. Chell, M.D.
Independent Director
Independent Director
--
--
Dr. C. David Nicholson, Ph.D.
Dr. C. David Nicholson, Ph.D.
Lead Independent Director
Lead Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Sandesh (Andes) Seth
Mr. Sandesh (Andes) Seth
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
5.38K
--
Dr. Ajit S. Shetty, Ph.D.
Dr. Ajit S. Shetty, Ph.D.
Independent Director
Independent Director
757.00
--
Mr. Richard I. Steinhart
Mr. Richard I. Steinhart
Independent Director
Independent Director
316.00
--
Mr. Steve O'Loughlin
Mr. Steve O'Loughlin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. June S. Almenoff, M.D., Ph.D.
Dr. June S. Almenoff, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Jeffrey W. Chell, M.D.
Dr. Jeffrey W. Chell, M.D.
Independent Director
Independent Director
--
--
收入明细
FY2024
暂无数据
地区USD
名称
营收
占比
United States
0.00
0.00%
业务
地区
暂无数据
股东统计
更新时间: 5月27日 周二
更新时间: 5月27日 周二
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
5.73%
The Vanguard Group, Inc.
4.40%
District 2 Capital LP
2.47%
Geode Capital Management, L.L.C.
2.28%
State Street Global Advisors (US)
2.07%
Other
83.05%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
5.73%
The Vanguard Group, Inc.
4.40%
District 2 Capital LP
2.47%
Geode Capital Management, L.L.C.
2.28%
State Street Global Advisors (US)
2.07%
Other
83.05%
股东类型
持股股东
占比
Investment Advisor
14.48%
Investment Advisor/Hedge Fund
10.07%
Hedge Fund
3.43%
Individual Investor
1.79%
Research Firm
0.76%
Pension Fund
0.14%
Bank and Trust
0.10%
Family Office
0.08%
Other
69.14%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
190
9.60M
30.78%
-2.97M
2025Q1
201
9.91M
31.75%
-2.62M
2024Q4
203
9.81M
31.44%
-2.78M
2024Q3
193
10.48M
34.47%
-136.85K
2024Q2
179
9.47M
32.33%
-512.57K
2024Q1
170
8.96M
30.96%
+85.09K
2023Q4
170
7.87M
28.74%
-1.58M
2023Q3
171
7.67M
28.80%
-1.27M
2023Q2
165
7.78M
29.70%
+701.53K
2023Q1
138
6.95M
27.77%
+572.16K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
1.79M
5.73%
-28.99K
-1.59%
Mar 31, 2025
The Vanguard Group, Inc.
1.57M
5.04%
-45.61K
-2.82%
Mar 31, 2025
District 2 Capital LP
769.45K
2.47%
-56.98K
-6.89%
Nov 08, 2024
Geode Capital Management, L.L.C.
711.80K
2.28%
+23.95K
+3.48%
Mar 31, 2025
State Street Global Advisors (US)
645.22K
2.07%
+24.14K
+3.89%
Mar 31, 2025
Acadian Asset Management LLC
504.04K
1.62%
+4.78K
+0.96%
Mar 31, 2025
Bigger (Michael)
450.17K
1.44%
-27.50K
-5.76%
Nov 08, 2024
UBS Financial Services, Inc.
396.14K
1.27%
+307.32K
+346.02%
Mar 31, 2025
Bigger Capital Funds, LP
235.69K
0.76%
-205.41K
-46.57%
Nov 08, 2024
Los Angeles Capital Management LLC
233.25K
0.75%
+19.30K
+9.02%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
Global X Russell 2000 Covered Call ETF
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Value ETF
0%
Dimensional US Core Equity 1 ETF
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
iShares Micro-Cap ETF
占比0.01%
Global X Russell 2000 Covered Call ETF
占比0%
ProShares Hedge Replication ETF
占比0%
ProShares UltraPro Russell2000
占比0%
iShares Russell 2000 Value ETF
占比0%
Dimensional US Core Equity 1 ETF
占比0%
Global X Russell 2000 ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0%
Proshares Ultra Russell 2000
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
公告日期
类型
比率
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
Aug 10, 2020
Merger
30<1
